5 Stocks Dragging The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 44 points (0.3%) at 15,464 as of Tuesday, Aug. 13, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,183 issues advancing vs. 1,800 declining with 78 unchanged.

The Health Services industry currently sits down 0.6% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Smith & Nephew ( SNN), up 0.6%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Mindray Medical International ( MR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mindray Medical International is down $0.64 (-1.5%) to $43.10 on average volume. Thus far, 346,949 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 724,000 shares. The stock has ranged in price between $42.76-$43.50 after having opened the day at $43.50 as compared to the previous trading day's close of $43.74.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $5.1 billion and is part of the health care sector. Shares are up 33.8% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Mindray Medical International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mindray Medical International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, St Jude Medical ( STJ) is down $0.45 (-0.8%) to $53.15 on light volume. Thus far, 652,274 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $52.89-$53.77 after having opened the day at $53.60 as compared to the previous trading day's close of $53.60.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $15.3 billion and is part of the health care sector. Shares are up 49.0% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate St Jude Medical a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Boston Scientific ( BSX) is down $0.09 (-0.8%) to $11.24 on light volume. Thus far, 5.1 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 18.7 million shares. The stock has ranged in price between $11.22-$11.40 after having opened the day at $11.35 as compared to the previous trading day's close of $11.33.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.3 billion and is part of the health care sector. Shares are up 98.1% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is down $2.37 (-0.6%) to $386.21 on average volume. Thus far, 286,282 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 569,000 shares. The stock has ranged in price between $378.59-$390.50 after having opened the day at $389.50 as compared to the previous trading day's close of $388.58.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.6 billion and is part of the health care sector. Shares are down 20.1% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is down $0.35 (-0.6%) to $54.87 on average volume. Thus far, 2.1 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.3 million shares. The stock has ranged in price between $54.65-$55.35 after having opened the day at $55.21 as compared to the previous trading day's close of $55.22.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $55.8 billion and is part of the health care sector. Shares are up 34.6% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets